| Pemphigoid diseases E Schmidt, D Zillikens The Lancet 381 (9863), 320-332, 2013 | 1140 | 2013 |
| Mechanisms of autoantibody-induced pathology RJ Ludwig, K Vanhoorelbeke, F Leypoldt, Z Kaya, K Bieber, ... Frontiers in immunology 8, 603, 2017 | 495 | 2017 |
| Pemphigus E Schmidt, M Kasperkiewicz, P Joly The Lancet 394 (10201), 882-894, 2019 | 474 | 2019 |
| Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid E Schmidt, K Obe, EB Bröcker, D Zillikens Archives of dermatology 136 (2), 174-178, 2000 | 427 | 2000 |
| Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany F Bertram, EB Bröcker, D Zillikens, E Schmidt JDDG: Journal der Deutschen Dermatologischen Gesellschaft 7 (5), 434-439, 2009 | 403 | 2009 |
| Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts DF Murrell, BS Daniel, P Joly, L Borradori, M Amagai, T Hashimoto, ... Journal of the American Academy of Dermatology 66 (3), 479-485, 2012 | 392 | 2012 |
| Diagnosis and management of pemphigus: Recommendations of an international panel of experts DF Murrell, S Peña, P Joly, B Marinovic, T Hashimoto, LA Diaz, AA Sinha, ... Journal of the American Academy of Dermatology 82 (3), 575-585. e1, 2020 | 367 | 2020 |
| Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) P Joly, B Horvath, Α Patsatsi, S Uzun, R Bech, S Beissert, R Bergman, ... Journal of the European Academy of Dermatology and Venereology 34 (9), 1900-1913, 2020 | 309 | 2020 |
| Modern diagnosis of autoimmune blistering skin diseases E Schmidt, D Zillikens Autoimmunity reviews 10 (2), 84-89, 2010 | 258 | 2010 |
| Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID) HP Tony, G Burmester, H Schulze-Koops, M Grunke, J Henes, I Kötter, ... Arthritis research & therapy 13, 1-14, 2011 | 257 | 2011 |
| IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity R Döpp, E Schmidt, I Chimanovitch, M Leverkus, EB Bröcker, D Zillikens Journal of the American Academy of Dermatology 42 (4), 577-583, 2000 | 241 | 2000 |
| Autoantibodies to bullous pemphigoid antigen 180 induce dermal–epidermal separation in cryosections of human skin C Sitaru, E Schmidt, S Petermann, LS Munteanu, EB Bröcker, D Zillikens Journal of investigative dermatology 118 (4), 664-671, 2002 | 237 | 2002 |
| The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement N Hunzelmann, E Genth, T Krieg, W Lehmacher, I Melchers, M Meurer, ... Rheumatology 47 (8), 1185-1192, 2008 | 235 | 2008 |
| Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial HC Williams, F Wojnarowska, G Kirtschig, J Mason, TR Godec, E Schmidt, ... The Lancet 389 (10079), 1630-1638, 2017 | 230 | 2017 |
| Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management KT Amber, DF Murrell, E Schmidt, P Joly, L Borradori Clinical reviews in allergy & immunology 54, 26-51, 2018 | 224 | 2018 |
| Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany F Hübner, A Recke, D Zillikens, R Linder, E Schmidt Journal of Investigative Dermatology 136 (12), 2495-2498, 2016 | 217 | 2016 |
| Rituximab in autoimmune bullous diseases: mixed responses and adverse effects E Schmidt, CS Seitz, S Benoit, EB Bröcker, M Goebeler British Journal of Dermatology 156 (2), 352-356, 2007 | 208 | 2007 |
| Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180 D Zillikens, F Caux, JM Mascaro Jr, U Wesselmann, E Schmidt, C Prost, ... Journal of investigative dermatology 113 (1), 117-121, 1999 | 193 | 1999 |
| Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases§ M Hertl, D Zillikens, L Borradori, L Bruckner‐Tuderman, H Burckhard, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 6 (5), 366-373, 2008 | 187 | 2008 |
| Enzyme‐linked immunosorbent assay using multimers of the 16th non‐collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies C Sitaru, C Dähnrich, C Probst, L Komorowski, I Blöcker, E Schmidt, ... Experimental dermatology 16 (9), 770-777, 2007 | 184 | 2007 |
